Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Genovese

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Endocrine Reviews|December 13, 2023
Endotrophin, a Key Marker and Driver for Fibroinflammatory DiseaseKim Henriksen, Federica Genovese, Alexander Reese-Petersen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 19, 2015
Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseasesMarios Papasotiriou, Federica Genovese, Barbara M Klinkhammer, et al.
Respiration; International Review of Thoracic Diseases|November 1, 2014
The role of extracellular matrix quality in pulmonary fibrosisJacob Hull Kristensen, Morten Asser Karsdal, Federica Genovese, et al.
Cardiovascular Diabetology|November 29, 2022
Endotrophin is a risk marker of complications in CANagliflozin cardioVascular Assessment Study (CANVAS): a randomized controlled trialDaniel Guldager Kring Rasmussen, Michael K Hansen, Joseph Blair, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|February 29, 2024
The role of fibrosis in cardiomyopathies: An opportunity to develop novel biomarkers of disease activityElisavet Angeli, Maria Jordan, Mandy Otto, et al.
Biomolecules|July 29, 2023
Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA NephropathyNadja Sparding, Michaela Neprasova, Dita Maixnerova, et al.
Frontiers in Endocrinology|July 14, 2025
Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapyTobias Stemann Lau, Lars Bossen, Daniel Guldager Kring Rasmussen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 21, 2022
Association between fibrosis markers and kidney function following peptide receptor radionuclide therapy in patients with neuroendocrine tumoursTobias Stemann Lau, Lars Bossen, Daniel Guldager Kring Rasmussen, et al.
Diabetes, Obesity & Metabolism|July 16, 2024
Association of type III collagen turnover with cardiovascular outcomes and impact with canagliflozin in the CANVAS Program: A post hoc analysisDaniel G K Rasmussen, Michael K Hansen, Peder Frederiksen, et al.
Geroscience|February 23, 2026
Circulating endotrophin reflects inflammaging and mortality risk in older adultsClara F G Laursen, Federica Genovese, Morten Baltzer Houlind, et al.
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Endocrine Reviews|December 13, 2023
Endotrophin, a Key Marker and Driver for Fibroinflammatory DiseaseKim Henriksen, Federica Genovese, Alexander Reese-Petersen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 19, 2015
Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseasesMarios Papasotiriou, Federica Genovese, Barbara M Klinkhammer, et al.
Respiration; International Review of Thoracic Diseases|November 1, 2014
The role of extracellular matrix quality in pulmonary fibrosisJacob Hull Kristensen, Morten Asser Karsdal, Federica Genovese, et al.
Cardiovascular Diabetology|November 29, 2022
Endotrophin is a risk marker of complications in CANagliflozin cardioVascular Assessment Study (CANVAS): a randomized controlled trialDaniel Guldager Kring Rasmussen, Michael K Hansen, Joseph Blair, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|February 29, 2024
The role of fibrosis in cardiomyopathies: An opportunity to develop novel biomarkers of disease activityElisavet Angeli, Maria Jordan, Mandy Otto, et al.
Biomolecules|July 29, 2023
Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA NephropathyNadja Sparding, Michaela Neprasova, Dita Maixnerova, et al.
Frontiers in Endocrinology|July 14, 2025
Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapyTobias Stemann Lau, Lars Bossen, Daniel Guldager Kring Rasmussen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 21, 2022
Association between fibrosis markers and kidney function following peptide receptor radionuclide therapy in patients with neuroendocrine tumoursTobias Stemann Lau, Lars Bossen, Daniel Guldager Kring Rasmussen, et al.
Diabetes, Obesity & Metabolism|July 16, 2024
Association of type III collagen turnover with cardiovascular outcomes and impact with canagliflozin in the CANVAS Program: A post hoc analysisDaniel G K Rasmussen, Michael K Hansen, Peder Frederiksen, et al.
Geroscience|February 23, 2026
Circulating endotrophin reflects inflammaging and mortality risk in older adultsClara F G Laursen, Federica Genovese, Morten Baltzer Houlind, et al.
Pageof 12